13 May Aspelone (Prednisolone Sodium Phosphate)
| Company name & Address: | registration number | Batch number(s) | Expiry date | Pack size | First release date | Re-call Classification | Recall date |
| Pharmacare Limited trading as Aspen Pharmacare
Healthcare Park, Woodlands Drive, Woodmead, 2196 |
41/21.5.1/0189 |
E0023605 |
June 2027 |
50ml |
15 October 2025 |
Class II Type B |
08 May 2026 |
Brief description of the problem (reason for recall)
This recall is initiated because incorrect labelling has been detected on a limited number of units of batch E0023605 of Aspelone liquid. Some Aspelone liquid 50ml bottles have been incorrectly labelled as Lenazine Forte Linctus. The outer carton, batch number and expiry date are correct and relate to batch E0023605 of Aspelone Liquid.
Advice for health professionals and distributors:
Aspen requests that you immediately return the affected batch to your supplier or distributor for credit without delay.
For further product information or medical queries, please call Aspen Pharmacare’s Medical Information Line on 0800 118 088.
Proposed action taken and its urgency: A SAHPRA-approved recall letter was distributed to all distribution points, and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.